Asco2016

ASCO 2016 melanoma highlights: immunotherapy developments and further data on checkpoint inhibitors

Dr Alex Menzies talks about ASCO 2016

Melanoma Institute Australia

Cancer Immunotherapy: ASCO’s 2016 Advance of the Year

ASCO 2016 Howard Kaufman Interview

Touch Medical Media

ASCO 2016 highlights for multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

What Cancer Patients Should Know: Latest Immunotherapy News from ASCO 2016

Cancer Research Institute

ASCO's 2016 Clinical Cancer Advances Report

ASCO 2016 – Treating Head and Neck Cancer – Promising Early Data for the Oral Inhibitor Buparlisib

GRACE - Global Resource for Advancing Cancer Education

ASCO 2016 highlights for immunotherapy

Dr Alex Menzies talks about highlights from ASCO 2016

Melanoma Institute Australia

ASCO 2016 highlights for CLL

VJHemOnc – Video Journal of Hematology & HemOnc

Gyn Onc at ASCO 2016: Cervical Cancer

Society of Gynecologic Oncology

ASCO 2016 – Treating Head and Neck Cancer – Immunotherapy as First-Line Treatment, Combinations

GRACE - Global Resource for Advancing Cancer Education

ASCO 2016 Update: Immunotherapy and Melanoma

Dana-Farber Cancer Institute

ASCO 2016: Plenary Session Review

ASCO 2016 – Treating Head/ Neck Cancer – Keynote 55: Pembrolizumab for Heavily Pre-Treated Pts

GRACE - Global Resource for Advancing Cancer Education

ASCO 2016 Review

Merck and Pfizer executives speak to TPL at ASCO 2016

The Pharma Letter

ASCO 2016 Nicola Fazio Interview

Touch Medical Media

ASCO 2016 – Treating Head and Neck Cancer – Using Biomarkers in Immunotherapy

GRACE - Global Resource for Advancing Cancer Education